FBTAX
Price
$26.76
Change
+$0.46 (+1.75%)
Updated
Jul 2 closing price
Net Assets
1.3B
RYCFX
Price
$40.80
Change
+$0.66 (+1.64%)
Updated
Jul 2 closing price
Net Assets
83.39M
Interact to see
Advertisement

FBTAX vs RYCFX

Header iconFBTAX vs RYCFX Comparison
Open Charts FBTAX vs RYCFXBanner chart's image
Fidelity Advisor Biotechnology A
Price$26.76
Change+$0.46 (+1.75%)
VolumeN/A
Net Assets1.3B
Rydex Biotechnology C
Price$40.80
Change+$0.66 (+1.64%)
VolumeN/A
Net Assets83.39M
FBTAX vs RYCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. RYCFX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and RYCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.3B vs. RYCFX (83.4M). FBTAX pays higher dividends than RYCFX: FBTAX (2.95) vs RYCFX (0.00). FBTAX was incepted earlier than RYCFX: FBTAX (25 years) vs RYCFX (24 years). RYCFX (2.43) is less costly to investors than FBTAX (0.96). FBTAX is a more actively managed with annual turnover of: 73.00 vs. RYCFX (51.00). FBTAX has a lower initial minimum investment than RYCFX: FBTAX (0) vs RYCFX (2500). FBTAX annual gain was more profitable for investors over the last year : -8.37 vs. RYCFX (-21.37). FBTAX return over 5 years is better than : -15.61 vs. RYCFX (-44.68).
FBTAXRYCFXFBTAX / RYCFX
Total Expense Ratio0.962.4040%
Annual Report Gross Expense Ratio0.962.4340%
Fund Existence25 years24 years-
Gain YTD-3.344-1.157289%
Front Load6%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B83.4M1,554%
Annual Yield % from dividends2.950.00-
Returns for 1 year-8.37-21.3739%
Returns for 3 years25.97-14.12-184%
Returns for 5 years-15.61-44.6835%
Returns for 10 years-9.37-53.6017%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZNCF143.884.17
+2.98%
AstraZeneca Plc
UBAAF4.68N/A
N/A
Urbana Corp.
CADLF4.60N/A
N/A
CADELER AS
EUXTF172.15N/A
N/A
Euronext NV
SLVDF0.16N/A
-2.66%
Silver Dollar Resources Inc.